Want to see HK:0867 full AI Analyst Report?
Total Valuation
China Medical System Holdings has a market cap or net worth of HK$27.44B. The enterprise value is HK$19.66B.
Market CapHK$27.44B
Enterprise ValueHK$19.66B
Share Statistics
China Medical System Holdings has 2,439,528,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,439,528,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
China Medical System Holdings’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 5.89%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)5.89%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee1.34M
Profits Per Employee342.46K
Employee Count6,141
Asset Turnover0.43
Inventory Turnover2.91
Valuation Ratios
The current PE Ratio of China Medical System Holdings is 16.0. China Medical System Holdings’s PEG ratio is -2.50.
PE Ratio16.0
PS Ratio3.41
PB Ratio1.61
Price to Fair Value1.61
Price to FCF114.89
Price to Operating Cash Flow31.07
PEG Ratio-2.50
Income Statement
In the last 12 months, China Medical System Holdings had revenue of 8.21B and earned 1.49B in profits. Earnings per share was 0.62.
Revenue8.21B
Gross Profit5.87B
Operating Income1.58B
Pretax Income2.10B
Net Income1.49B
EBITDA1.82B
Earnings Per Share (EPS)0.62
Cash Flow
In the last 12 months, operating cash flow was 758.42M and capital expenditures -514.41M, giving a free cash flow of 244.01M billion.
Operating Cash Flow758.42M
Free Cash Flow244.01M
Free Cash Flow per Share0.10
Dividends & Yields
China Medical System Holdings pays an annual dividend of HK$0.155, resulting in a dividend yield of 2.26%
Dividend Per ShareHK$0.155
Dividend Yield2.26%
Payout Ratio22.79%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.91
52-Week Price Change-6.83%
50-Day Moving Average11.50
200-Day Moving Average13.16
Relative Strength Index (RSI)42.02
Average Volume (3m)6.44M
Important Dates
China Medical System Holdings upcoming earnings date is Aug 13, 2026, TBA (Confirmed).
Last Earnings DateMar 16, 2026
Next Earnings DateAug 13, 2026
Ex-Dividend Date―
Financial Position
China Medical System Holdings as a current ratio of 6.33, with Debt / Equity ratio of 3.97%
Current Ratio6.33
Quick Ratio5.78
Debt to Market Cap0.02
Net Debt to EBITDA-1.10
Interest Coverage Ratio77.77
Taxes
In the past 12 months, China Medical System Holdings has paid 659.78M in taxes.
Income Tax659.78M
Effective Tax Rate0.31
Enterprise Valuation
China Medical System Holdings EV to EBITDA ratio is 14.26, with an EV/FCF ratio of 106.64.
EV to Sales3.17
EV to EBITDA14.26
EV to Free Cash Flow106.64
EV to Operating Cash Flow34.31
Balance Sheet
China Medical System Holdings has HK$5.79B in cash and marketable securities with HK$690.37M in debt, giving a net cash position of HK$5.10B billion.
Cash & Marketable SecuritiesHK$5.79B
Total DebtHK$690.37M
Net CashHK$5.10B
Net Cash Per ShareHK$2.09
Tangible Book Value Per ShareHK$5.10
Margins
Gross margin is 71.50%, with operating margin of 19.22%, and net profit margin of 18.13%.
Gross Margin71.50%
Operating Margin19.22%
Pretax Margin25.61%
Net Profit Margin18.13%
EBITDA Margin22.22%
EBIT Margin19.22%
Analyst Forecast
The average price target for China Medical System Holdings is HK$19.48, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$19.48
Price Target Upside37.15% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast10.00%
EPS Growth Forecast-7.54%